Trimetozine

Trimetozine
Systematic (IUPAC) name
morpholin-4-yl-(3,4,5-trimethoxyphenyl)methanone
Clinical data
AHFS/Drugs.com International Drug Names
  • ℞ (Prescription only)
Oral
Identifiers
635-41-6
None
PubChem CID 12478
ChemSpider 11968
UNII 31EPT7G9PL Yes
ChEMBL CHEMBL1697853
Chemical data
Formula C14H19NO5
281.304 g/mol

Trimetozine (Opalene, Trimolide, Trioxazine) is a sedative that has been marketed in Europe since 1959.[1][2] It also has mild tranquilizing effects and has been used in the treatment of anxiety.[3][4] Its mechanism of action is unclear.

References

  1. ↑ Swiss Pharmaceutical Society (2000). Index Nominum 2000: International Drug Directory (Book with CD-ROM). Boca Raton: Medpharm Scientific Publishers. p. 1932. ISBN 3-88763-075-0.
  2. ↑ David J. Triggle (1997). Dictionary of pharmacological agents. London: Chapman & Hall. ISBN 0-412-46630-9.
  3. ↑ Taverna P, Ferrari G (June 1970). "[Clinical trial of a new tranquilizing agent: trioxazine]". Minerva Medica (in Italian) 61 (46): 2574–90. PMID 5425739.
  4. ↑ Shpak VM, Shcheglova AIu (August 1968). "[Trioxazine in the treatment of night anxiety in children]". Pediatriia (in Russian) 47 (8): 76–7. PMID 5730033.